INSERM and SNOMED International work together on rare diseases
While individual rare diseases
affect only a small percentage of the European population, they collectively
affect up to 30 million people in the EU. Being able to share European data for
research and innovation would benefit patients all over Europe (European Rare Disease research Coordination and support Action).
The Institut national de la santé et de la recherche
médicale (Inserm) and SNOMED International have created a map from SNOMED CT to
the Orphanet Nomenclature of Rare Diseases (INSERM, SNOMED International and Orphanet).